Literature DB >> 33739452

The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.

Yan Zhao1, Lijuan Yin2,3,4,5, Jenil Patel6,7, Lei Tang1, Ying Huang2.   

Abstract

To conduct a systematic review and meta-analysis to characterize inflammatory markers in comparisons of multisystem inflammatory syndrome in children (MIS-C) versus severe/non-severe COVID-19, severe MIS-C versus non-severe MIS-C, and among age groups of MIS-C. Nine databases were searched for studies on inflammatory markers of MIS-C. After quality checks, data were pooled using a fixed or random effects model. Inflammatory markers included white blood cell count (WBC) or leukocytes, absolute lymphocyte count (ALC), absolute neutrophil count (ANC), platelet count (PLT), C-reactive protein (CRP), procalcitonin (PCT), ferritin, D-dimer, lactate dehydrogenase (LDH), fibrinogen, and erythrocyte sedimentation rate (ESR) for comparisons by severity and age. Twenty-one studies with 1735 participants yielded 787 MIS-C patients. Compared to non-severe COVID-19 patients, MIS-C patients had lower ALC and higher ANC, CRP, and D-dimer levels. Compared to severe COVID-19 patients, MIS-C patients had lower LDH and PLT counts and higher ESR levels. Severe MIS-C patients had higher levels of WBC, ANC, CRP, D-dimer, and ferritin than non-severe MIS-C patients. For MIS-C, younger children (0-5 years) had lower CRP and ferritin levels than middle-aged/older children/adolescents. Measurement of inflammatory markers might assist clinicians in accurate evaluation and diagnosis of MIS-C and the associated disorders.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; MIS-C/PMIS/PIMS-TS; SARS-CoV-2; inflammatory markers; meta-analysis; pediatrics

Year:  2021        PMID: 33739452     DOI: 10.1002/jmv.26951

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Multisystem Inflammatory Syndrome in Children (MIS-C) With Hematological Manifestations: A Case Report.

Authors:  Yazeid Alrefaey; Ahmad Alamoudi; Reshale Johar; Rawia F Albar
Journal:  Cureus       Date:  2022-04-11

Review 2.  Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.

Authors:  Rahnuma Ahmad; Mainul Haque
Journal:  Vaccines (Basel)       Date:  2022-04-14

3.  Clinical Predictors of Subacute Myocardial Dysfunction in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19.

Authors:  Daniel McAree; Amanda Hauck; Jennifer Arzu; Michael Carr; Jennifer Acevedo; Ami B Patel; Nazia Husain
Journal:  Pediatr Cardiol       Date:  2022-10-19       Impact factor: 1.838

4.  Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.

Authors:  Gülçin Otar Yener; Ayşenur Paç Kısaarslan; Kadir Ulu; Erdal Atalay; Fatih Haşlak; Semanur Özdel; Burcu Bozkaya Yücel; Deniz Gezgin Yıldırım; Figen Çakmak; Kübra Öztürk; Mustafa Çakan; Zeynep Balık; Canan Hasbal Akkuş; Mehmet Yıldız; Tuğba Erat; Benhur Şirvan Çetin; Münevver Yılmaz; Esra Bağlan; Sibel Laçinel Gürlevik; Vildan Atasayan; Şerife Gül Karadağ; Amra Adrovic; Şengül Çağlayan; Ayşe Tanatar; Fatma Gül Demirkan; Taner Coşkuner; Özlem Akgün; Müşerref Kasap Cüceoğlu; Gülşah Kavrul Kayaalp; Sezgin Şahin; Özge Başaran; Ferhat Demir; Kenan Barut; Murat Çiftel; Dolunay Gürses; Ali Baykan; Yasemin Özsürekçi; Tevfik Karagöz; Hafize Emine Sönmez; Yelda Bilginer; Nuray Aktay Ayaz; Özlem Aydoğ; Selçuk Yüksel; Betül Sözeri; Özgür Kasapçopur; Seza Özen
Journal:  Rheumatol Int       Date:  2021-09-07       Impact factor: 3.580

5.  Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children.

Authors:  Fatih Haslak; Kenan Barut; Cansu Durak; Ayten Aliyeva; Mehmet Yildiz; Vafa Guliyeva; Sevki Erdem Varol; Sinem Oral Cebeci; Fatih Aygun; Yusuf Ziya Varli; Abdulrahman Ozel; Sertac Hanedan Onan; Ulkem Kocoglu; Meltem Erol; Fatih Karagozlu; Nujin Ulug; Reyhan Dedeoglu; Sezgin Sahin; Amra Adrovic; Funda Oztunc; Ozgur Kasapcopur
Journal:  Clin Rheumatol       Date:  2021-06-05       Impact factor: 2.980

6.  The Role of Lung Ultrasound in Diagnosing COVID-19-Related Multisystemic Inflammatory Disease: A Preliminary Experience.

Authors:  Anna Maria Musolino; Elena Boccuzzi; Danilo Buonsenso; Maria Chiara Supino; Maria Alessia Mesturino; Eugenio Pitaro; Valentina Ferro; Raffaella Nacca; Serena Sinibaldi; Paolo Palma; Alberto Villani; Paolo Tomà
Journal:  J Clin Med       Date:  2022-01-01       Impact factor: 4.241

7.  CXCL10/IP10 as a Biomarker Linking Multisystem Inflammatory Syndrome and Left Ventricular Dysfunction in Children with SARS-CoV-2.

Authors:  Eviç Zeynep Başar; Hafize Emine Sönmez; Hüseyin Uzuner; Aynur Karadenizli; Hüseyin Salih Güngör; Gökmen Akgün; Ayşe Filiz Yetimakman; Selim Öncel; Kadir Babaoğlu
Journal:  J Clin Med       Date:  2022-03-04       Impact factor: 4.241

Review 8.  Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?

Authors:  Daniel D Reiff; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2022-02-12       Impact factor: 4.686

9.  A young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy.

Authors:  Yosuke Mohri; Mariko Shimizu; Tadao Fujimoto; Yuki Nishikawa; Akiko Ikeda; Yusuke Matsuda; Taizo Wada; Chiharu Kawaguchi
Journal:  IDCases       Date:  2022-03-31

10.  The Multifaceted Presentation of the Multisystem Inflammatory Syndrome in Children: Data from a Cluster Analysis.

Authors:  Hafize Emine Sönmez; Şengül Çağlayan; Gülçin Otar Yener; Eviç Zeynep Başar; Kadir Ulu; Mustafa Çakan; Vafa Guliyeva; Esra Bağlan; Kübra Öztürk; Demet Demirkol; Ferhat Demir; Şerife Gül Karadağ; Semanur Özdel; Nuray Aktay Ayaz; Betül Sözeri
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.